Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of HCV NS5B polymerase

Inhibitors of HCV NS5B polymerase

US Patent 7041690 · Granted May 9, 2006

Estimated economic value: $36,237,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations for treatment of NAFLD/NASH and related diseases2025
Liposomes and uses thereof2023
Benzimidazole derivatives and their uses2022
Synthetic polypeptides and uses thereof2022
PDE4D inhibitors2021
Triazolopyridine compounds and methods for the treatment of cystic fibrosis2019
Pyridazinone compounds and methods for the treatment of cystic fibrosis2019
Compounds and methods for the treatment of cystic fibrosis2018
Triazolopyridine compounds and methods for the treatment of cystic fibrosis2018
Pyridazinone compounds and methods for the treatment of cystic fibrosis2017
Pyridazinone compounds and methods for the treatment of cystic fibrosis2017
Compounds and methods for the treatment of cystic fibrosis2017